Back to search

University of Patras

Συσχέτιση των νευροϊνιδίων χαμηλού μοριακού βάρους (NfL) και άλλων γενετικών βιοδεικτών με τη νευροτοξικότητα που προκαλείται από τη χορήγηση χημειοθεραπείας

Abstract

dc:description

Background and Objective: There is compelling experimental evidence that neurofilament light chain (NfL) could sensitively be detected in serum as a biomarker of neuro-axonal damage induced by chemotherapy. We sought to assess the significance of measuring serum NfL (sNfL) in the clinical setting of paclitaxel-induced peripheral neurotoxicity (PIPN). Materials and methods: We longitudinally measured sNfL in breast cancer patients, scheduled to receive the 12-weekly paclitaxel-based regimen. Patients were clinically examined by means of the Total Neuropathy Score–clinical version (TNSc), while sNfL levels were quantified, using the highly-sensitive Simoa technique, before the onset of chemotherapy (baseline), after 2 (week 2) and 3 (week 3) weekly courses, and at the end of chemotherapy (week 12). Results: Among 59 included patients (mean age: 53.1 ± 11.5 years), 33 (56%) developed grade 0-1 and 26 (44%) grade 2-3 PIPN at week 12. A significant longitudinal increase of sNfL levels from baseline to week 12 was determined, whereas patients with TNSc grade 2-3 PIPN had significantly increased sNfL levels at week 12, compared to those with grade 0-1 PIPN. Receiver-operated characteristics (ROC) analysis defined a value of NfL of > 85 pg/mL at week 3 as the best discriminative determination to predict the development of grade 2-3 PIPN at week 12 (sensitivity 46.2%, specificity 84.8%). The logistic binary regression analysis revealed that age > 50 years and the cutoff of >85 pg/mL of sNfL levels at week 3 independently predicted the development of grade 2-3 PIPN at week 12 with a sensitivity of 46%, a specificity of 91%, and positive and negative predictive values of 75% and 67%, respectively. Conclusions: NfL levels seem to be a valuable biomarker of neuro-axonal injury in PIPN. An early increase of this biomarker after a 3-weekly chemotherapy course can be a predictive marker of final PIPN severity.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Karteri, Sofia
  • Καρτέρη, Σοφία

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/55060

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Karteri, Sofia; Καρτέρη, Σοφία. Συσχέτιση των νευροϊνιδίων χαμηλού μοριακού βάρους (NfL) και άλλων γενετικών βιοδεικτών με τη νευροτοξικότητα που προκαλείται από τη χορήγηση χημειοθεραπείας. University of Patras, 2023. http://hdl.handle.net/10442/hedi/55060